2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide

C29H32N6O3 — CID 160789477

IUPAC2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide
SMILESCc1ncc(-c2ccnc(C(C)(C)C(=O)NCCN3CCOCC3)c2)nc1-c1cc(-c2ccccc2)no1
InChIInChI=1S/C29H32N6O3/c1-20-27(25-18-23(34-38-25)21-7-5-4-6-8-21)33-24(19-32-20)22-9-10-30-26(17-22)29(2,3)28(36)31-11-12-35-13-15-37-16-14-35/h4-10,17-19H,11-16H2,1-3H3,(H,31,36)
InChIKeyVCVHWYQTDPTKFS-UHFFFAOYSA-N
MW512.61 g/mol
LogP3.90
Rot. Bonds8

About 2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide

2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide (PubChem CID 160789477) has the molecular formula C29H32N6O3 and a molecular weight of 512.61 g/mol. Its IUPAC name is 2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide.

Molecular Properties

Compound Name2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide
PubChem CID160789477
Molecular FormulaC29H32N6O3
Molecular Weight512.61 g/mol
Exact Mass512.25
IUPAC Name2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide
SMILESCc1ncc(-c2ccnc(C(C)(C)C(=O)NCCN3CCOCC3)c2)nc1-c1cc(-c2ccccc2)no1
InChIInChI=1S/C29H32N6O3/c1-20-27(25-18-23(34-38-25)21-7-5-4-6-8-21)33-24(19-32-20)22-9-10-30-26(17-22)29(2,3)28(36)31-11-12-35-13-15-37-16-14-35/h4-10,17-19H,11-16H2,1-3H3,(H,31,36)
InChIKeyVCVHWYQTDPTKFS-UHFFFAOYSA-N
XLogP3.90
TPSA106.27 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms38
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500512.61
LogP ≤ 53.90
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze 2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide?
The IUPAC name of 2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide (CID 160789477) is 2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide.
What is the SMILES notation for 2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide?
The canonical SMILES for 2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide is Cc1ncc(-c2ccnc(C(C)(C)C(=O)NCCN3CCOCC3)c2)nc1-c1cc(-c2ccccc2)no1.
What is the InChIKey of 2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide?
The InChIKey is VCVHWYQTDPTKFS-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H32N6O3/c1-20-27(25-18-23(34-38-25)21-7-5-4-6-8-21)33-24(19-32-20)22-9-10-30-26(17-22)29(2,3)28(36)31-11-12-35-13-15-37-16-14-35/h4-10,17-19H,11-16H2,1-3H3,(H,31,36).
What are the key properties of 2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide?
2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide has a molecular weight of 512.61 g/mol, XLogP of 3.90, 8 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-methyl-2-[4-[5-methyl-6-(3-phenyl-1,2-oxazol-5-yl)pyrazin-2-yl]-2-pyridinyl]-N-(2-morpholin-4-ylethyl)propanamide is sourced from PubChem (CID 160789477), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).